<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: therapeutic outcome</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Two specific agents worse than one in treating endocrine resistant breast cancer cells</title>
   	 <description>A new class of agents known as c-Src inhibitors is being tested in a number of different ways to treat breast cancer, but researchers at Georgetown Lombardi Comprehensive Cancer Center caution that they should not be used in combination with estrogen to treat endocrine resistant breast cancer.</description>
     <link>http://medicalxpress.com/news/2012-04-specific-agents-worse-endocrine-resistant.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 02 Apr 2012 15:50:01 EST</pubDate>
	 <guid isPermaLink="false">news252586174</guid>
	 
</item>


</channel>
</rss>
